Table 2.
Surgical data for patients undergoing bilateral breast reconstruction.
n (%) | |
---|---|
Therapeutic surgery (known disease) | 45 (82) |
Prophylactic surgery (no known disease) | 10 (18) |
Immediate reconstruction | 41 (75) |
After prophylactic mastectomy | 8 (15) |
After therapeutic mastectomy | 33 (60) |
Delayed reconstruction, mean delay (years) | 8 (15) |
After prophylactic mastectomy | 2 (3.6) |
After therapeutic mastectomy | 6 (11) |
Immediate/delayed | 6 (11) |
Abdominal donor | 55 (100) |
DIEP | 41 (75) |
TRAM | 7 (13) |
SIEA | 1 (1.8) |
Combination | 6 (11) |
Average ischaemic time (mins) | 68.57 |
Recipient vein | |
Internal mammary | 100 (90) |
Serratus | 4 (3.6) |
Thoracodorsal | 2 (1.8) |
Additional perforator | 4 (3.6) |
Recipient artery | |
Internal mammary | 106 (96) |
Serratus | 2 (1.8) |
Thoracodorsal | 2 (1.8) |
Average flap size (g) | 692.25 |
Peri/post-op blood transfusion | 8 (15) |
Average hospital stay (days) | 7.5 |
Average follow-up (months) | 46.1 |
Adjuvant chemotherapy only | 8 (15) |
Adjuvant radiotherapy only | 6 (11) |
Adjuvant chemoradiotherapy | 23 (42) |